Core Viewpoint - MIRXES-B (02629) has successfully completed a share placement, raising approximately HKD 711 million, with net proceeds of about HKD 673 million after costs and expenses [1] Group 1: Share Placement Details - The board announced that all conditions for the share placement were met, and the transaction was completed on February 5, 2026 [1] - A total of 21.888 million shares were successfully placed at a price of HKD 32.50 per share to no fewer than six independent subscribers [1] - The net price per share after costs is approximately HKD 30.77 [1] Group 2: Use of Proceeds - Approximately 30% of the net proceeds will be allocated for investment and acquisition activities [1] - About 25% will be used for research and development, including clinical studies of existing pipelines and development of new pipelines [1] - Around 20% will be directed towards expanding into emerging markets [1] - The remaining 25% will be utilized for general operational purposes [1]
MIRXES-B(02629)完成配售合共2188.8万股配售股份，净筹约6.73亿港元